European Neuropsychopharmacology, 4 (1994) 547 548 ,© 1994 Elsevier Science B.V. All rights reserved 0924-977X/94/$07.00
547
Contents of Volume 4 (1994)
Number
1 - March
1994
Research papers The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients J. Lundmark, J. Wdlinder, C. Ailing, P.M. Manniche and L. Dalgaard (Sweden, Denmark) Lack of association between platelet tritiated imipramine binding and clinical status of depressed patients on chronic antidepressant treatment B. Gronier, J.M. Azorin, D. Dassa and R. Jeanningros (France) Increased trimipramine plasma levels during fluvoxamine comedication E. Seifritz, E. Holsboer-Trachsler, U. Hemmeter, C. Bin Eap and P. Baumann (Switzerland) Functional properties of the brain during sleep under subchronic zopiclone administration in man J. R6schke, K. Mann, J.B. Aldenhoff and O. Benkert (German),) Genotypic differences in locomotor stimulation and dopaminergic activity following acute ethanol administration S. Liljequist and K. Ossowska (Sweden) The effect of haloperidol and naloxone on excessive grooming behavior of cats T. Willemse, M. Mudde, M. Joseph)' and B.M. Spruijt (The Netherlands) Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo G.B. Cassano, C. Toni, A. Petracca, J. Deltito, O. Benkert, G. Curtis, H. Hippius, W. Maier, D. Shera and G. Klerman (Italy, USA, Germany) Are serotonergic reuptake inhibitors more potent in reducing suicidality? An empirical study on paroxetine H.-J. M611er and E.M. Steinmeyer (Germany) Guidelines on psychotropic drugs for the EC Newsletter Book reviews Announcement
Number
7 15 21 31 39
47 55 61 79 81 83
2 - June 1994
Review articles Anxiolytic drugs: dependence, addiction and abuse M. Lader (UK) New animal models of anxiety B. Olivier, E. Molewijk, R. van Oorschot, G. van der Poel, T. Zethof, J. van der Heyden and J. Mos (The Netherlands) Research papers NMDA-GABA interactions in an animal model of behaviour: a gating mechanism from motivation toward psychotic-like symptoms M. Sabatino, C. Cannizzaro, A. Flugy, M. Gagliand, A. Mineo and G. Cannizzaro (Italy) Experimental estimation of addictive potential of a mixture of organic solvents L. Yavich, N. Patkina and E. Zvartau (Russia) Plasma reduced haloperidol/haloperidol ratios in schizophrenic patients treated with high dosages of haloperidol W.-H. Chang, Y.-S. Shieh, H.-C. Liu, M.W. Jann and C.-P. Chien (Taiwan, USA) Subchronic treatment with the neuroleptic-like peptide desenkephalin-7-endorphin may decrease dopaminergic neurotransmission in the nucleus accumbens of rats F.S. Radhakishun, B.H.C. Westerink, J.C. Stool', G. Wolterink and J.M. van Ree (The Netherlands) Locomotor and analgesic effects of morphine and acetorphan in rats chronically treated with morphine or thiorphan R. Khallouk-Bousselmame and J. Costentin (France) Double-blind study of mirtazapine and placebo in hospitalized patients with major depression H. Vartiainen, E. Leinonen (Finland) Electrically evoked potentials in the rat hippocampus slice in the presence of aminophylline alone and in combination with quinolones W. Dimpfel, A. Dalhoff W. Hofmann and G. Schliiter (Germany) Summary report on short-acting hypnotics Announcements
85 93
103 111 119
127 137 145
151 157 161
548 Number
3 - September
1994
Abstracts of the Vllth Congress ~?]"the European College of Neuropsychoparmacology
Number
4 - December
1994
Research papers The selective histamine Hi -receptor agonist 2-(3-trifluoromethylphenyl)histamineincreases waking the rat J-M. Montia, H. Jantosa, C. Leschkeb, S. Elzb and W. Schunackb (Uruguay, German),) Behavioral evidence for the existence of two pools of cellular inositol Y. Bersudsky, Z. Kaplan, Y. Shapiro, .G Agamb, O. Kofman and R.H. Belmaker (Israel) Brain ATP:L-methionine S-adenosyltransferase (MAT), S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH): regional distribution and age-related changes C. Gomes Trolin, C. Lofberg, G. Trolin and L. Oreland (Sweden) A trial of carbamazepine in borderline personality disorder J.M. De la Fuente and F. Lotstra (Belgium) CSF inositol in schizophrenia and high-dose inositol treatment of schizophrenia J. Levine, L Goldberger, A. Rapaport, M. Schwartz, C. Schield, A. Elizur, R.H. Belmaker, J. Shapiro and G. Agarn (Israel) Multiunit activity from the A9 and AI0 areas in rats following chronic treatment with different neuroleptic drugs A. Todorova and W. Dimpfel (Germany) Effects of antagonists at the NMDA receptor complex in two models of anxiety A. Plaznik, W. Palejko, M. Nazar and M. Jessa (Poland) Prolactin and TSH responses to TRH and to haloreridol in schizophrenic patients before and after treatment M. Markianos, J. Hatzimanolis and C. Stefanis (Greece) TSH response to TRH and EEG sleep in non-bipolar major depression: a multivariate approach Ph.P. Hubain, L. Staner, M. Dramaix, M. Kerkhofs, C. van Veeren, G. Papadimitriou, J. Mendlewicz and P. Linkowski (Belgium, Luxembourg, Greece) Kappa opioid receptor agonists inhibit the pilocarpine-induced seizures and toxicity in the mouse B. Przew|ocka, H. Machelska and W. Lasoh (Poland) Some unusual effects of ~2-adrenergic drugs on cortical high voltage spindles in rats L. Yavich, J. Sirvi& A. Haapalinna and P. Riekkinen Sr. (Finland)
459 463
469 479 487 491 503 513
517 527 535
Author Index (Vol. 4)
539
Key Word Index ( Vol. 4)
541
Contents of Volume 4
547